AION Labs is a venture studio dedicated to building and investing in startups that leverage AI to revolutionize drug discovery and development. It is a unique partnership formed by AstraZeneca, Merck, Pfizer, Teva, the Israel Biotech Fund, Amiti Ventures, and AWS. AION Labs combines deep pharmaceutical R&D expertise with cutting-edge AI to create de-risked, industry-aligned ventures. Through its co-development model, startups gain early access to pharma insights, R&D champions, and real-world validation opportunities — alongside structured company-building support and funding. In three years, AION Labs has launched nine companies, delivered multiple pharma pilots and collaborations across drug R&D, and achieved strong market validation through follow-on funding, up-rounds, and a strategic M&A.
| Website | http://www.aionlabs.com |
| Employees | 22 (15 on RocketReach) |
| Founded | 2021 |
| Industry | Biotechnology Research |
| Keywords | Artificial Intelligence, Ai Technology, Drug Discovery, Drug Development, Machine Learning, Data Science, Deep Learning, Biotechnology, Pharmaceutical, Big Data, Healthcare, Innovation, Analytics, Research, Technology, Venture Studio, Software, Solutions, Platform |
| Competitors | Amazon, Microsoft, IBM, Salesforce, NVIDIA, OpenAI, DataRobot, Element AI, a ServiceNow company, AI Community, By P Digital Marketing +42 more (view full list) |
Looking for a particular AION Labs employee's phone or email?
Mati Gill is the CEO of AION Labs.
15 people are employed at AION Labs.